Cardiogen

Cardiogen

Cardiogen is a research-grade tetrapeptide of Russian bioregulator origin, developed for preclinical investigation of cardiac tissue function and myocardial biology. As part of the Khavinson peptide bioregulator series, Cardiogen is a short-chain peptide designed to interact with cardiac cell DNA and modulate gene expression associated with cardiomyocyte function and tissue homeostasis. It is supplied as a lyophilised extract for use in in vitro and in vivo research models.

Mechanism of Action

Cardiogen is hypothesised to act as a gene expression modulator, interacting with chromatin and influencing the transcription of genes involved in cardiac cell differentiation, protein synthesis, and tissue repair. Peptide bioregulators of this class are thought to exhibit tissue-specific activity by binding to complementary DNA sequences in target cells, thereby restoring or maintaining normal cellular function in aged or damaged tissue. Research has focused on its potential role in cardiomyocyte viability and functional recovery in experimental models.

Research Applications

• Cardiomyocyte biology and cardiac tissue homeostasis studies
• Peptide bioregulator gene expression modulation research
• Myocardial function and recovery modelling
• Ageing and cellular senescence investigation in cardiac tissue
• Cytoprotection and tissue-specific peptide activity studies

Specifications

• Molecular Formula: C₁₈H₃₁N₇O₉
• CAS Number: N/A
• Purity: ≥98%
• Molecular Weight: 489.48 g/mol
• Form: Lyophilised extract
• Storage: -20°C
• Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for diagnostic, therapeutic, or consumer use.